Matthew Bryant
National Center for Toxicological Research(US)United States Food and Drug Administration(US)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, Pharmacogenetics and Drug Metabolism, Mass Spectrometry Techniques and Applications, Analytical Chemistry and Chromatography, Effects and risks of endocrine disrupting chemicals
Most-Cited Works
- Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.(1998)
- Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.(1987)
- → Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.(1988)192 cited
- → Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90(2014)163 cited
- → Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses(2019)144 cited
- → Differential Effects of Silver Nanoparticles and Silver Ions on Tissue Accumulation, Distribution, and Toxicity in the Sprague Dawley Rat Following Daily Oral Gavage Administration for 13 Weeks(2016)134 cited
- → Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents